Ethnicity
& Disease (ISSN:
1049-510X) is published
quarterly. An annual subscription
is included with ISHIB
membership or available
to individuals and institutions.
To purchase an annual
subscription or this particular
issue click
here.
|
SELECT
PROCEEDINGS AND ABSTRACT
PRESENTATIONS FROM ISHIB2009,
CHICAGO, ILLINOIS
View
Article |
Foreword
View
Article |
Keith
C. Ferdinand, MD, FACC,
FAHA; Keith C. Norris,
MD, FASN |
Basic
Principles of Effective
Hypertension Therapeutics
View
Article
|
John
M. Flack, MD, MPH, FAHA,
FACP |
Provider
Factors Affecting Adherence:
Cultural Competency and
Sensitivity
View
Article
|
Debra
J. Barksdale, PhD, FNP |
Vitamin
D and Chronic Kidney Disease
View
Article
|
Sandra
Williams, MD; Karla Malatesta,
BS; Keith Norris, MD |
ABSTRACT
PRESENTATIONS from
the 24th International
Interdisciplinary Conference
on Hypertension and Related
Risk Factors in Ethnic
Minority Populations
View
Article
|
|
001
DIABETES & STROKE
HOSPITALIZED PATIENTS
IN 2006: AN ANALYSIS OF
HEALTHCARE COST BY RACE
AND GENDER
|
BA
HUSAINI; V Cain; Z Samad;
KB Merchant; RS Levine;
M Moonis |
002
BLOOD PRESSURE AND HYPERTENSION
AMONG DUTCH AFRICANS,
SOUTH ASIANS, BRITISH
AFRICANS AND SOUTH ASIANS:
A CROSS NATIONAL COMPARATIVE
STUDY
|
C
AGYEMANG; R Bhopal; PZaninotto;
N Unwin; J Nazroo; A Kunst;
K Stronks |
003
EFFICACY OF THE VASODILATING,
SELECTIVE B-BLOCKER NEBIVOLOL
AS AN ADD-ON TO OTHER
ANTIHYPERTENSIVES IN OBESE
PATIENTS
|
K
FERDINAND |
004
EFFECT OF NEBIVOLOL IN
OBESE AFRICAN AMERICAN
PATIENTS WITH HYPERTENSION
|
K
FERDINAND |
005
ETHNIC DIFFERENCES IN
RESPONSE TO INITIAL TREATMENT
WITH VALSARTAN MONOTHERAPY
OR COMBINATION VALSARTAN/HYDROCHLOROTHIAZIDE
(HCTZ) IN PATIENTS WITH
STAGE 2 HYPERTENSION
|
JM
FLACK; D Levy; A Rudolph |
006
INHIBITION OF HIV1 REPLICATION
AND RESTORATION OF GLUCOSE,
LIPIDS, HEMOGLOBIN LEVELS
AND NITRIC OXIDE (NO)
IMBALANCE IN HIV1 PATIENTS
FROM GABON
|
G
Maka; J Loundou; PV MAVOUNGOU;
MY Akoume Ndong; B Ongali;
E Mavoungou; D Mavoungou |
007
CHANGES IN GLUTATHIONE
METABOLISM IN HYPERTENSIVE
AFRICAN AMERICAN WOMEN
|
H
YANG; G Shan; LC Zhou;
X Lin; ZM Guo |
008
HEALTH LITERACY AND LANGUAGE
PREFERENCE IN HISPANICS
WITH CHRONIC KIDNEY DISEASE
|
CM
LORA; L Ackerson; C Anderson;
M Bruce; E Carmona; B
Gerber; E Lustigova; A
Narva; L Nessel; SE Rosas;
A Sehgal; S Steigerwalt;
J Vijil; AS Go; JP Lash |
009
BUILDING PARTNERSHIPS
IN URBAN COMMUNITIES THROUGH
FOCUS GROUPS
|
DE
JONES; B Weaver; WJohnson;
E Saunders |
010
DELAYED DIAGNOSIS/MANAGEMENT
OF PRIMARY ALDOSTERONISM
— HELP FROM THE
WEB: A SUPPORT GROUP FOR
PATIENTS STRUGGLING WITH
THIS COMMON CAUSE OF DIFFICULT-TOCONTROL
HIGH BLOOD PRESSURE.
|
CE
Grim; S Hall S; V Murphy;
HM PEARSON and the 500+
members of hyperaldosteronism
at Yahoogroups.com |
011
PREVALENCE OF HTN IN AN
HIV CLINIC IN NIGERIA:
AN EPIDEMIC WITHIN AN
EPIDEMIC?
|
EO
Ofondu; RA Onwuegbuchulam;
CN Osondu; R Nwogu; WOkoro;
CE GRIM |
012
QUALITY IMPROVEMENT FOR
BLOOD PRESSURE (BP) MEASUREMENT:
EFFECT OF TRAINING ON
TERMINAL DIGIT PREFERENCE
IN AN URBAN INTERNAL MEDICINE
CLINIC
|
A
DALMAR; A Caceres; CE
Grim; CM Grim |
013
EFFICACY OF AN AMLODIPINE/OLMESARTAN
MEDOXOMIL (AML/OM)-BASED
TITRATION REGIMEN IN OBESE
OR NON-OBESE PATIENTS
WITH HYPERTENSION
|
H
PUNZI; A Shojaee; J-F
Maa; N Patel |
014
EFFICACY OF OLMESARTAN
MEDOXOMIL (OM) AND HYDROCHLOROTHIAZIDE
(HCTZ) IN ELDERLY (65
YEARS) PATIENTS WITH HYPERTENSION:
A POST HOC ANALYSIS OF
PATIENTS WITH
ISOLATED SYSTOLIC HYPERTENSION
|
DJ
KEREIAKES; J-F Maa; R
Dubiel; A Shojaee |
015
IMPACT OF RACE ON BP REDUCTION
AND GOAL ACHIEVEMENT OF
OLMESARTAN MEDOXOMILBASED
TREATMENT IN PATIENTS
WITH TYPE 2 DIABETES
|
JM
NEUTEL; A Lewin; J-F Maa;
A Shojaee; R Dubiel |
016
THE COMBINATION OF AMLODIPINE
+ OLMESARTAN MEDOXOMIL
PROVIDES NUMERICALLY GREATER
REDUCTIONS IN BLOOD PRESSURE
COMPARED WITH COMPONENT
MONOTHERAPIES
IN RACE AND ETHNIC SUBGROUPS
|
S
OPARIL; D Ramstad; M Melino;
J Lee; R Heyrman |
017
EFFICACY OF AN AMLODIPINE/OLMESARTAN
MEDOXOMIL (AML/OM)-BASED
TITRATION REGIMEN IN BLACK
OR NON-BLACK PATIENTS
WITH HYPERTENSION
|
DJ
KEREIAKES; JM Neutel;
A Shojaee; WF Waverczak;
R Dubiel; J-F Maa |
018
EFFICACY OF AN AMLODIPINE/OLMESARTAN
MEDOXOMIL (AML/OM)-BASED
TITRATION REGIMEN IN PATIENTS
WITH OR WITHOUT DIABETES
AND HYPERTENSION
|
H
PUNZI; A Lewin; T Littlejohn
III; A Shojaee; WF Waverczak;
R Dubiel; J-F Maa |
019
THE ASSOCIATION BETWEEN
HEALTH LITERACY AND GLYCEMIC
CONTROL AMONG MEXICAN
AMERICAN DIABETICS WITH
CHRONIC KIDNEY DISEASE:
A PRELIMINARY REPORT FROM
THE PASO DEL NORTE KIDNEY
DISEASE STUDY (PNKDS)
|
P
Ragland; N Vega; A Fester;
D Vasquez; T Alhamad;
S Connery; F Madero; R
Alfaro; J Dahu; F Payan;
M Chauvet; P Tarwater;
GT HERNANDEZ |
020
NEBIVOLOL IN HIGH-RISK,
OBESE AFRICAN AMERICANS
WITH STAGE 1 HYPERTENSION:
EFFECTS ON BLOOD PRESSURE,
NITRIC OXIDE BIOAVAILABILITY,
AND VASCULAR FUNCTION
|
N
MERCHANT; T Haque; CD
Searles; A Pandian; I
Bridges; ST Rahman; KC
Ferdinand; BV Khan |
021
THE METABOLIC SYNDROME
DOES NOT EFFECTIVELY IDENTIFY
DIABETES RISK IN BLACK
AFRICANS: RESULTS OF A
PILOT COMPARISON OF BLACK
AFRICANS AND AFRICAN AMERICANS
|
M
Luercio; M Ricks; F Thomas;
OE Imoisili; BV Miller;
NA Avila; AE SUMNER |
022
PREVALENCE AND PATTERN
OF METABOLIC SYNDROME
IS SIMILAR IN WEST AFRICANS
AND AFRICAN AMERICANS
|
AE
SUMNER; J Zhou; A Doumatey;
OE Imoisili; CN Rotimi |
023
RELATIONSHIP BETWEEN INFLAMMATION
AND HYPERTENSION IN BLACKS
|
RE
WATSON; C Pereira-Hicks;
KV Sarikonda; VPKotaru;
GD Fink |
024
A COMPARATIVE STUDY OF
PREVALENCE AND MANAGEMENT
OF ARTERIAL HYPERTENSION
IN THE FRENCH CARIBBEAN
REGION AND MAINLAND FRANCE
|
V
ZIZKA; N Ozier-Lafontaine;
J Inamo |
025
FAITH-BASED DASH LIFESTYLE
PROGRAM FOR HYPERTENSION
CONTROL IN AFRICAN AMERICANS
CHURCH COMMUNITIES- PROGRAM
OVERVIEW
|
S
DODANI; D Sullivan; J
Rankins; M Mayo; L Appel;
A Ely; J Ard |
026
THE IMPACT OF PATIENT
EDUCATION AND PHYSICIAN
EDUCATION ON BLOOD PRESSURE
CONTROL
|
E
SAUNDERS; W Johnson; F
Shaya; B Weaver; CD Mullins;
D Howard; C Foster; X
Yan; N Norman |
027
THE IMPROVEMENT OF DIABETES
CONTROL AND DISEASE PROCESS
AWARENESS AS A RESULT
OF FACE-TO-FACE VS MAIL
INTERVENTION AMONG PATIENTS
WITH DIABETES MELLITUS
|
R
Winston; E SAUNDERS; F
Shaya; A Laird; Z Lu;
F Larkins; CD Mullins;
S Jolly; W Johnson; B
Weaver |
